NCT05772819

Brief Summary

Surgery remains an important treatment modality in the treatment of hepatopancreatobiliary (HPB) malignancies, but the physiological stress caused by surgery is at the same time a challenge for the homeostasis of patients. A patient's preoperative aerobic capacity has been found to have a consistent relation with postoperative outcomes in major abdominal surgery, with low aerobic capacity being associated with a higher risk of postoperative morbidity and mortality. Preoperative exercise prehabilitation programs can effectively increase the ability of patients to cope with surgical-induced allostatic load, by improving aerobic capacity, and functioning of the respiratory, cardiovascular, and/or musculoskeletal systems. However, besides the effect of exercise prehabilitation on physical fitness in terms of improvement of aerobic capacity as measured by the cardiopulmonary exercise test (CPET), the exact role of adaptations in cardiac and/or skeletal muscle function contributing to the improvement in aerobic capacity is still unknown. Insight in the physiological adaptations that lead to improvement in aerobic capacity after prehabilitation in patients with low aerobic capacity will enable caregivers to individually optimize the exercise program (e.g. by changing exercise frequency, intensity, duration and type) and better explain the rationale and effectiveness behind the short-term physical exercise training program to patients. Therefore, the main objective of this study is to assess the central (cardiac function) and peripheral (skeletal muscle function) physiological adaptations in response to short-term exercise prehabilitation. Secondary objective is to assess the relationship between immune function and exercise. In this study, unfit patients are asked to undergo additional in-magnet exercise testing to investigate the central and peripheral physiological adaptations in response to exercise prehabilitation.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 10, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 16, 2023

Completed
16 days until next milestone

Study Start

First participant enrolled

April 1, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2024

Completed
Last Updated

March 16, 2023

Status Verified

March 1, 2023

Enrollment Period

1 year

First QC Date

February 10, 2023

Last Update Submit

March 6, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Central physiological adaptations

    Central adjustments will be determined by differences in LV/RV diastolic strain rate, LV and RV volumes, slope of early LV/RV filling, left and right atrial reservoir strain and emptying fraction, pulmonary artery distensibility and pulsatility, and cardiac output measurements using exCMR, before and after the prehabilitation program.

    through study completion, an average of 1 year

  • Peripheral physiological adaptations

    Peripheral adjustments will be determined by differences in quadriceps PCr, Pi and pH at rest and during progressive exercise and post-exercise recovery rates of quadriceps PCr, Pi and pH using 31P MRS, before and after the prehabilitation program.

    through study completion, an average of 1 year

Secondary Outcomes (1)

  • Postoperative outcomes

    through study completion, an average of 1 year

Study Arms (1)

Imaging arm

EXPERIMENTAL

Participants are subjected to in-magnet exercise test consisting of in vivo exercise cardiac magnetic resonance (exCMR) imaging and 31P-magnetic resonance spectroscopy (31P-MRS) during exercise testing in a MR-compatible ergometer, before and after the 4-week prehabilitation program.

Diagnostic Test: exercise MRI

Interventions

exercise MRIDIAGNOSTIC_TEST

All patients are subjected to two types of in-magnet exercise tests consisting of exercise cardiac magnetic resonance imaging (exCMR) and Phosphorus 31 magnetic resonance spectrography (31P MRS) of the quadriceps muscle, during exercise at various exercise intensities in a supine position using a MR-compatible ergometer (Lode MR Ergometer Pedal, Lode BV, Groningen, the Netherlands).

Imaging arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • VO2 at the VAT ≤13 ml/kg/min and/or VO2peak ≤18 ml/kg/min, as determined during the baseline CPET;
  • More than 18 years of age;
  • Scheduled for elective liver- or pancreatic resection at the UMCG;
  • Willing to participate in the home-based bimodal prehabilitation program;
  • Has given consent to participate in the study.

You may not qualify if:

  • Patients requiring acute (emergency) surgery;
  • Patients not capable of cycling on a cycle ergometer;
  • Patients with contraindications to physical exercise training;
  • Patients receiving neoadjuvant chemotherapy
  • Contraindications for exCMR (e.g., claustrophobia, implanted cardiac devices)
  • Atrial fibrillation or other significant arrhythmia during the CPET;
  • Body weight \>140 kg;
  • Body height \>190 cm;
  • History of myocardial infarction, percutaneous coronary intervention or coronary artery bypass graft \<3 months or untreated severe obstructive coronary artery stenosis;
  • More than moderate left-sided valve disease;
  • Complex congenital heart disease.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Medical Center Groningen

Groningen, 9713GZ, Netherlands

Location

Related Publications (1)

  • Wijma AG, Driessens H, Jeneson JAL, Janssen-Heijnen MLG, Willems TP, Klaase JM, Bongers BC. Cardiac and intramuscular adaptations following short-term exercise prehabilitation in unfit patients scheduled to undergo hepatic or pancreatic surgery: study protocol of a multinuclear MRI study. BMJ Open Gastroenterol. 2023 Nov 23;10(1):e001243. doi: 10.1136/bmjgast-2023-001243.

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 10, 2023

First Posted

March 16, 2023

Study Start

April 1, 2023

Primary Completion

April 1, 2024

Study Completion

June 1, 2024

Last Updated

March 16, 2023

Record last verified: 2023-03

Locations